Blaine McKee
Director/Board Member bei VBI VACCINES INC.
Vermögen: - $ am 31.03.2024
Profil
Blaine H.
McKee is currently the President & Chief Executive Officer at Walden Biosciences, Inc. He is also a Director at OrbiMed Israel Partners LP and an Independent Director at VBI Vaccines, Inc. Previously, he held positions such as Director at ArmaGen, Inc., Independent Director at Harvard Apparatus Regenerative Technology, Inc., Director at New York Pharma Forum, Inc., Chief Business Officer & Executive Vice President at ImmunoGen, Inc., Senior Vice President-Strategic Development at Genzyme Corp., Senior VP & Head-Corporate Development at Shire Plc, and Chief Business Officer & Executive Vice President at Lyra Therapeutics, Inc. Dr. McKee received his doctorate from Massachusetts Institute of Technology, his undergraduate degree from Colorado State University, and his MBA from MIT Sloan School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VBI VACCINES, INC.
-.--% | 27.07.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Blaine McKee
| Unternehmen | Position | Beginn |
|---|---|---|
| VBI VACCINES INC. | Director/Board Member | 11.01.2019 |
OrbiMed Israel Partners LP
 OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | Director/Board Member | - |
Walden Biosciences, Inc.
 Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | Chief Executive Officer | 01.01.2020 |
Ehemalige bekannte Positionen von Blaine McKee
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOGEN, INC. | Corporate Officer/Principal | 31.12.2019 |
New York Pharma Forum, Inc.
 New York Pharma Forum, Inc. Information Technology ServicesTechnology Services New York Pharma Forum, Inc. provides information technology services for the healthcare industry. The private company is based in New York, NY. | Director/Board Member | 01.01.2019 |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Director/Board Member | 04.06.2018 |
| SHIRE | Corporate Officer/Principal | 01.04.2018 |
ArmaGen, Inc.
 ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Director/Board Member | 01.01.2017 |
Ausbildung von Blaine McKee
| Massachusetts Institute of Technology | Doctorate Degree |
| Colorado State University | Undergraduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| IMMUNOGEN, INC. | Health Technology |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Health Technology |
| LYRA THERAPEUTICS, INC. | Health Technology |
| VBI VACCINES INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
OrbiMed Israel Partners LP
OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | Finance |
ArmaGen, Inc.
ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | Health Services |
New York Pharma Forum, Inc.
New York Pharma Forum, Inc. Information Technology ServicesTechnology Services New York Pharma Forum, Inc. provides information technology services for the healthcare industry. The private company is based in New York, NY. | Technology Services |
Walden Biosciences, Inc.
Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | Health Services |
